Yatırımcı.AI

USUSD

Akebia Ther

Akebia Ther AKBA

—
Market cap
USD 247.5M

Key Data

USD 247.5M
USD −0.12
52 weeks
0.843.17
1-year return
−67.76%
Avg. volume (200d)
4.5M
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic

Technical Signals

Technical signals

Only our Plus members can access this area.

AI Models

AI models

Only our Plus members can access this area.

About Akebia Ther

Market capitalization is 247.5M USD, earnings per share −0.12 USD, the price-to-earnings ratio — and the dividend yield —. The company operates in the Healthcare sector, within the Drug Manufacturers - Specialty & Generic industry. The 52-week range is 0.84 – 3.17 USD; the one-year return is −67.76%.

Frequently Asked Questions

Price data for AKBA is temporarily unavailable and will refresh with the next update.

US stocks such as Akebia Ther (AKBA) can be bought through Turkish brokerage firms (aracı kurumlar) that offer access to foreign markets. You open an account enabled for foreign equity trading; because US stocks trade in dollars, the account and trades are in USD, so lira savings are converted to dollars first. The regular session on the NYSE and Nasdaq runs from 09:30 to 16:00 New York time, which is 16:30–23:00 Türkiye time while US daylight saving time is in effect and 17:30–00:00 otherwise. Taxation is subject to Turkish tax law; check the Revenue Administration (GİB) for current rules.

AKBA trades at a price-to-earnings ratio of —, with earnings per share of −0.12 USD and a market capitalization of 247.5M USD. Ratios use the latest reported results and the current price.

Over the past 52 weeks AKBA traded between 0.84 and 3.17 USD; the one-year return is −67.76%.

The current dividend yield of AKBA is —. Dividend yield is the annual cash dividend divided by the share price; the company may change its policy.

Akebia Ther (AKBA) is listed on the US stock market; its sector is Healthcare and its industry is Drug Manufacturers - Specialty & Generic.

Prices, volume and fundamentals come from licensed data providers; prices are delayed by at least 15 minutes and fundamentals refresh daily. AI forecasts are generated by Yatırımcı.AI models and are not investment advice.